rate for HD varies substantially between populations, and that IA frequency and haplotype are closely linked to observed epidemiological differences in the prevalence of HD across major ancestry groups in different countries. show that up to one in 7,300 people are affected with HD in Western populations, with the majority of prevalence estimates ranging between 9.71 and 13.7 per 100,000 (Baig et al., 2016; Rawlins et al., 2016) . Strikingly, HD manifests at less than one-twentieth this rate in East Asian populations from Japan, Korea, Taiwan, and Hong Kong (0.1-0.7 per 100,000) (Adachi & Nakashima, 1999; Chang et al., 1994; Chen & Lai, 2010; Kay et al., 2014; Kim et al., 2015) . In South Africa, HD in black people occurs at approximately one-tenth the rate in the white subpopulation, and approximately one-third the rate in the mixed ancestry subpopulation (Baine, Krause, & Greenberg, 2016) . In British Columbia, Canada, HD is much more prevalent among individuals of European descent (17.2 per 100,000) than in the ethnically diverse remainder of the population (2.1 per 100,000) . Taken together, these epidemiological observations suggest that major population differences in the prevalence of HD are attributable to ethnic ancestry and are principally genetic in nature.
K E Y W O R D S
Differences in the prevalence of HD by ancestry may be related to the new mutation rate for HD. New mutations occur as a result of CAG repeat expansion, usually in the paternal germline, resulting in a disease-associated genotype of 36 CAG repeats or more in offspring (Duyao et al., 1993; Goldberg et al., 1993) . CAG trinucleotides encode the amino acid glutamine and expanded polyglutamine tracts in HTT are pathological, resulting in a toxic gain-of-function to the HTT protein (Bates et al., 2015) . Intermediate alleles (IAs), defined as 27-35 CAG repeats, have the potential for germline expansion into the HD range, with risk of expansion increasing across the IA repeat range (Semaka, Creighton, Warby, & Hayden, 2006; Semaka, Kay, Doty, Collins, Bijlsma, et al., 2013) . IA frequency has been estimated from 2.9% to 3.4% of alleles in representative population samples of European ancestry, with an IA genotype in as many as one in 15 individuals from the general population (i.e., approximately 3.3% allele frequency, which corresponds to a 6.7% genotypic or carrier frequency among individuals in the population) Ramos et al., 2012; Semaka, Kay, Doty, Collins, Tam, et al., 2013; Sequeiros et al., 2010) . The dramatically lower prevalence of HD in non-European populations may result from a lower IA frequency and hence a lower new mutation rate in these ancestry groups, with fewer CAG expansion events and a consequent lower incidence of the disease (Andrew & Hayden, 1995) . However, the frequency of IAs has not been assessed in non-European ancestry groups with lower prevalence rates of HD, and thus no comparative estimates of IA frequency or the HD new mutation rate are currently available.
Haplotypes refer to groups of genetic variants that tend to be inherited together, a phenomenon that can be used to track inheritance patterns as well as be employed in allele-specific silencing therapeutic approaches for HD (Kay et al., 2015) . In European ancestry populations, where the prevalence of HD is highest, expanded CAG repeats causative of HD are found preferentially on specific genespanning HTT haplotypes (A1, A2, and A3a) (Kay et al., 2015) which are defined by specific single nucleotide polymorphisms and short insertion/deletion variants. IAs (27-35 CAG) and high-normal CAG repeat alleles (20) (21) (22) (23) (24) (25) (26) are similarly enriched for these haplotypes in comparison to normal CAG repeat alleles in European-ancestry populations, suggesting that high-normal CAG repeats expand into the IA and HD repeat ranges (Almqvist et al., 1995; Rubinsztein, Leggo, Goodburn, Barton, & Ferguson-Smith, 1995; Warby et al., 2009 ). In East Asian and black South African populations, where the prevalence of HD is low, these European ancestry HD-associated haplotypes are entirely absent, high-normal CAG repeats are less frequent, and the HD mutation instead occurs on a diverse assortment of populationspecific haplotypes (Baine et al., 2013; Warby et al., 2011) . It remains unclear whether HTT haplotypes of IAs are reflective of populationspecific HD haplotypes in non-European ancestry groups. In admixed ancestry patient groups, with suspected European origins of the mutation, such as the mixed ancestry subpopulation of South Africa, it is unknown whether the mutation results from a comparatively recent HD mutation founder or from numerous, distinct European-ancestry IAs that expanded after admixture (Scholefield & Greenberg, 2007) .
Evaluation of IA frequency and haplotype in distinct ethnic groups may therefore clarify the genetic origin of HD in different non-European ancestry populations.
In this comparative genetic study, we genotyped the CAG repeat in general population chromosomes from a wide range of ancestry groups in North America, Europe, South America, Africa, and East Asia.
We characterize the CAG repeat distribution, high-normal allele frequency, IA frequency, and HD new mutation rate in a series of populations where recent prevalence estimates based on molecular KAY ET AL. | 347 data are available for comparison. In the current study, we present the most comprehensive analysis of IA frequencies in diverse global populations, to our knowledge. We show that population differences in disease prevalence are associated with high-normal allele frequency, IA frequency, and the inferred HD new mutation rate. We further show that the prevalence of HD correlates with the proportion of IAs on the A1 haplotype in different European-ancestry populations. Our study thus provides an empirical framework for understanding the molecular epidemiology of HD worldwide, showing that high-normal allele frequency, IA frequency, and the HD new mutation rate are closely linked to epidemiological differences in disease prevalence, both within and between major ancestry groups.
| MATERIALS AND METHODS

| Study populations
Saliva-extracted DNA samples from North Americans were obtained from the Coriell Personalized Medicine Collaborative (CPMC) Community Cohort (Keller et al., 2010) . Participants were not recruited on the presence or absence of any disease phenotype. 3,907 individuals were genotyped from the CPMC cohort as previously described , of whom 3,221 provided data on self-declared ethnicity. Individuals with self-declared ethnicity as Figure S1 ) using representative genome-wide markers in the ADME Core Panel (Illumina, San Diego, CA) as previously described (Kay, Tirado-Hurtado, et al., 2016 
| HTT haplotyping
General population individuals with at least one repeat allele of 27-35
CAG were genotyped at 90 SNPs across HTT as previously described (Kay et al., 2015) . Reconstructed haplotypes were phased to CAG repeat length by haplotype-specific CCG and CAG repeat length associations (Kay et al., 2015; Semaka, Kay, Doty, Collins, Tam, et al., 2013) , or by homozygosity of haplotype or CAG size.
| Estimation of the HD new mutation rate
For each sample group, the general population frequency of each intermediate allele (CAG 27, 28, 29, etc.) was multiplied by the corresponding male germline expansion rate of that CAG repeat length into the HD range (Semaka, Kay, Doty, Collins, Bijlsma, et al., 2013) , yielding a predicted population rate of paternal HD expansions from each specific IA CAG repeat length. The population rate of paternal HD expansion from each specific IA CAG repeat length was then summed across the IA range (CAG 27-35), yielding an estimated total population rate of paternal expansions from IAs to the HD range (≥36 CAG) in each population. Paternal germline transmissions are expected to occur randomly among different CAG repeat alleles in the population and maternal IA expansions into the HD range are extremely rare IAs were observed in all population groups except for East Asians. 
| High mean CAG repeat length is attributable to HD-associated haplotypes in European ancestry populations
Dense HTT haplotyping of patients and relatives in the UBC HD Biobank allowed for detailed examination of the distribution of CAG repeat lengths by haplotype in normal chromosomes. In our prior investigation of four European-ancestry patient cohorts, we identified 20 common gene-spanning HTT haplotypes constituting >95% of all normal chromosomes (Kay et al., 2015) . Four of these haplotypes-A1, A2a, A2b, and A3a-were found to represent >90%
of HD mutation haplotypes in decreasing order of frequency among The mean CAG repeat length of all 804 unrelated normal HTT haplotypes in the UBC HD Biobank was 18.7, comparable to other
European ancestry general population samples reported here and in previous studies (Tables 1 and S2 ). When HD-associated haplotypes in the UBC Biobank were excluded (A1, A2, and A3a) from this pool of normal chromosomes, mean CAG repeat length declined to 17.4, comparable to mean CAG repeat length in East Asian and black African populations where the prevalence of HD is much lower (Table 1 ).
These data suggest that longer mean CAG repeat length and higher IA frequency in European-ancestry populations are attributable to specific gene-spanning haplotypes with high-normal CAG repeat length (A1, A2, and A3a). Higher IA frequency and prevalence of HD in European-ancestry populations relative to black Africans and East
Asians may therefore result from the presence of these higher mean CAG repeat lengths on specific HD-associated haplotypes, which were found in the general population of European ancestry but not in populations of black African or East Asian ancestry.
| IAs occur on ancestry-specific HTT haplotypes in ethnically distinct populations
Haplotypes of IAs in the UBC HD Biobank reflect our previously reported haplotypes of the HD mutation in the Canadian population ( Figure 2f ) (Kay et al., 2015 
| The HD new mutation rate correlates with the manifest prevalence rate of HD
We recently reported empirical CAG repeat length-specific IA expansion rates in the male germline, enabling evidence-based standards of IA expansion risk in genetic counseling practice (Semaka & Hayden, 2014; Semaka, Kay, Doty, Collins, Bijlsma, et al., 2013) .
These male germline instability rates were comparable to paternal transmission instability rates observed in the UBC HD Biobank at similar CAG repeat lengths (Table S3 ). Using CAG-specific IA frequencies from the largest population samples in this study, in combination with our reported CAG-specific IA expansion rates, we could estimate the molecular HD new mutation rate in each population. We calculated this inferred HD new mutation rate for Our data directly demonstrated this correlation across a range of global populations. We showed that populations with a higher prevalence of HD had: (1) higher mean CAG repeat length and highnormal frequency among normal chromosomes; (2) higher IA frequency; and (3) a higher inferred HD new mutation rate. High mean CAG repeat length in European-ancestry populations was attributable to higher frequencies of the A1, A2, and A3a haplotypes in these populations, which have higher mean CAG repeat lengths than the population average. These haplotypes were absent in East Asian and black African populations where average CAG repeat length and the prevalence of HD are correspondingly lower. Taken together, our analysis offers a rational explanation for the differing prevalence rates of HD around the world which may be verified from genetic and epidemiological data in additional populations.
Among HD-associated haplotypes in European-ancestry populations, the A1 haplotype shows the highest mean CAG repeat length and the strongest association with the HD mutation (Kay et al., 2015) .
We showed that the proportion of IAs on the A1 haplotype was associated with IA frequency and the HD new mutation rate, suggesting that a higher frequency of the A1 haplotype in the general population may result in a higher prevalence of the disease. The A1 haplotype is found in South Asian individuals (Kay et al., 2015) and a distinct A1 variant haplotype is found at high frequency in admixed Latin American populations (Kay, Tirado-Hurtado, et al., 2016) , suggesting that de novo HD mutations may occur in these populations at a similar rate to populations of European ancestry.
It was notable that the highest average CAG length across all 15 populations examined in this study was among Hispanic Americans (Table 1; 19.0, , which is nearly identical to that observed among normal chromosomes genotyped in a clinical cohort from Mexico (19.04) (Alonso et al., 2009) . It should, however, be noted that the sample size of Hispanic American alleles included in this study is relatively small (n = 160) and the confidence intervals for this estimate overlap with those calculated for both the white South African and Northern Scottish cohorts. Hispanic Americans in our study were found to have the highest IA frequency of all evaluated groups (5.6%). In line with these observations, a recent systematic review of global IA prevalence observed that the highest IA frequency in the general population detected to date (8.7%) was found in Brazilians (Apolinario, Paiva, & Agostinho, 2017) .
These data suggest that the genetic prevalence rate of HD in admixed populations of Latin America may in fact exceed the prevalence rate in populations of predominant European ancestry. However, only a limited number of studies reporting IA frequencies for Latin America are available (Apolinario et al., 2017 ) and recent population-based prevalence estimates of HD for most of the region are unavailable (Castilhos et al., 2015; Paradisi, Hernandez, & Arias, 2008; Rawlins et al., 2016) . The term Hispanic broadly refers to persons of Latin American or Spanish descent, representing a heterogonous group of individuals with varying degrees of admixture from European, African, and Native
American ancestry (Bedoya et al., 2006; Gravel et al., 2013) . This admixture is reflected in our data, with a high proportion of Hispanic IA samples (22%) carrying the B2 haplotype, which is observed in mixed Among European ancestry populations, the lowest reported prevalence rate based on molecular data was in the Finnish population (Sipila et al., 2014) . This is thought to result from the genetic isolation of the Finnish people relative to other European populations, leading to divergent disease allele frequencies (Kere, 2001) . As previously reported, our data showed lower mean CAG repeat length among IAs from black South Africans occurred on an assortment of haplotypes of African origin, similar to the diverse background of African haplotypes observed in black South African HD chromosomes (Baine et al., 2013 expansion from affected ancestors has resulted in a locally high frequency of the mutation (Wexler et al., 2004) . In such populations, haplotypes of the HD mutation are expected to be shared between affected descendants of a founder. We also observed the HD mutation on the A3a haplotype in DNA from four distantly related Venezuelan patients, known to be part of the extended founder pedigree in this population. We hypothesize that the founder mutation in this population occurred on the A3a haplotype, and that all affected descendants of this founder likewise share the HD mutation on A3a. As such, de novo HD mutations may have played a minor role in the high prevalence of HD in the Maracaibo region of Venezuela relative to high birth rates from a single pedigree within a limited geographic area.
In order to perform a global assessment of the relationship between IA frequency and HD prevalence, it was necessary to include various individual prevalence studies to obtain the relevant information. Since these studies differ in design, they can be prone to different biases and we have highlighted the methods of ascertainment in supplementary Table S4 . Despite these complications, our analysis suggests that differences in IA frequency alone can explain observed HD prevalence rates in major ethnic groups. Differences in cis or trans genetic background may nonetheless modify the instability of highnormal CAG repeat alleles or IAs. An instability-modifying haplotype has been reported in SCA3 (Martins et al., 2008) and undiscovered cis factors in HTT CAG repeat instability cannot be excluded by our data.
However, such cis modifiers do not appear to be necessary to explain the molecular epidemiology of HD as a function of high-normal allele and IA frequency by population. High-normal CAG repeat lengths on specific haplotypes in European ancestry populations (A1, A2a, A2b, and A3a) may have resulted from drift of CAG repeat length early in the evolution of these haplotype lineages, which over many generations resulted in higher population frequencies of IAs occurring on these haplotypes (Falush, 2009) . It is notable that the A1 and A2a haplotypes are the most genetically diverged European-ancestry haplotypes within the A haplogroup, indicating that these haplotypes acquired high-normal CAG repeat lengths independently rather than by common inheritance of instability-promoting sequences in the surrounding genomic region.
Ancestry-specific differences in prevalence are a hallmark of many trinucleotide repeat disorders (TNRs), including myotonic dystrophy (DM) (Theadom et al., 2014 ), Friedreich's ataxia, dentatorubralpallidoluysian atrophy (DRPLA), and various spinocerebellar ataxias (SCAs) (Ruano, Melo, Silva, & Coutinho, 2014) . Where studied, a higher prevalence of a given TNR disorder typically coincides with enrichment for longer normal alleles in the same population, often attributable to one or more haplotypes on which long normal alleles are preferentially found to occur (Cossee et al., 1997; Imbert, Kretz, Johnson, & Mandel, 1993; Liquori et al., 2003) . Our study, which comparatively analyzed IA frequency across populations with differing prevalence rates of HD, suggests that populations enriched for long normal alleles in other TNRs may also have higher premutation allele frequencies and consequently higher new mutation rates.
Our population-based estimate of the HD new mutation rate among individuals of predominant European ancestry was substantially higher than prior extrapolations in this population. Conditional probability estimates of de novo HD transmission risk constructed from the prevalence of North American patients without family history suggested that 1/6,241-1/951 transmissions from a father with an IA genotype will result in a new mutation for HD (Hendricks et al., 2009 ).
Our population-based estimates showed that the risk of a new HD mutation for any given paternal transmission in the population already overlaps this range (one in 5,372), and is roughly an order of magnitude higher among transmissions from fathers with a confirmed IA, particularly at repeat lengths approaching the HD range. Our population-based estimate of the HD new mutation rate is roughly two orders of magnitude higher than indirect estimates predating mapping of the CAG repeat expansion (Shaw & Caro, 1982) , in stark contradiction to prior assumptions that the HD new mutation rate is low. We instead showed that new mutations for HD are likely common in the population in comparison to de novo mutations causative of other genetic diseases. Other genetic and environmental factors may modulate the high new mutation rate calculated here and should be delineated in future studies.
Future molecular and clinical studies will be necessary to validate our inferred HD new mutation rates. In particular, our rates include expansion events into the reduced penetrance range (36) (37) (38) (39) where manifestation of HD occurs later in life or perhaps not at all. It is therefore important to consider not only the rate of expansion into the HD range (≥36 CAG) but also the penetrance of the resulting allele in individuals inheriting a de novo HD genotype. We recently revealed a high frequency of reduced penetrance alleles in the European-ancestry general population, suggesting that the population prevalence of individuals with a de novo expansion into the reduced penetrance range (36-39 CAG) could exceed the number of individuals who go on to clinically manifest HD (Kay, Tirado-Hurtado, et al., 2016 HD but are at high risk of further repeat expansion in offspring, the number of individuals who present with HD symptoms without a family history may not correspond to the inferred genetic new mutation rate presented in our study.
In conclusion, we showed that the average CAG repeat length, 
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